Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREMARIN® INTRAVENOUS Contraindications (conjugated estrogens)


Premarin Intravenous therapy should not be used in individuals with any of the following conditions:

  1. Undiagnosed abnormal genital bleeding.
  2. Known, suspected, or history of breast cancer.
  3. Known or suspected estrogen-dependent neoplasia.
  4. Active DVT, PE or a history of these conditions.
  5. Active arterial thromboembolic disease (for example, stroke and MI) or a history of these conditions.
  6. Known anaphylactic reaction and angioedema to Premarin Intravenous therapy.
  7. Known liver dysfunction or disease.
  8. Known protein C, protein S, or antithrombin deficiency or other known thrombophilic disorders.
  9. Known or suspected pregnancy.
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event